BONST
ZBH icon

Bank of Nova Scotia Trust’s Zimmer Biomet ZBH Stock Holding History

Bank of Nova Scotia Trust’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-989
Closed -$112K – 412
2017
Q3 		$112K Buy
+989
New +$114K 0.01% 172

Other funds holding ZBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of Nova Scotia Trust's ZBH Position: Q4 2017 in Review

Bank of Nova Scotia Trust sold out of Zimmer Biomet (ZBH) in Q4 2017, closing a stake of 989 shares — an estimated $112K sold.

Bank of Nova Scotia Trust first reported a position in ZBH in Q3 2017 and held it in 1 quarter. The position peaked at $112K in Q3 2017. 870 funds tracked by Wall St. Rank hold ZBH as of Q4 2017.

  • Bank of Nova Scotia Trust reported no remaining Zimmer Biomet position as of Q4 2017 after selling out during the quarter.
  • Bank of Nova Scotia Trust sold 989 Zimmer Biomet shares in Q4 2017, an estimated $112K.
  • Bank of Nova Scotia Trust first reported a position in Zimmer Biomet in Q3 2017 and held it in 1 quarter.
  • Bank of Nova Scotia Trust's Zimmer Biomet position peaked at $112K in Q3 2017.
  • 870 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2017.

Based on Bank of Nova Scotia Trust's 13F filing for Q4 2017, filed 13 Feb 2018.